drugset / Trial / NCT03546868
Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
Diagnostic validity of \[18F\]FSPG for assessing disease activity will be assessed in subjects with inflammatory bowel disease.
Timeline
- Start
- 2018-08-14
- Primary completion
- 2019-01-11
- Completion
- 2019-01-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-FSPG | Diagnostic / imaging agent | 200 mbq | — |